This consultation ran from to
The MHRA is seeking views on the reclassification from pharmacy to general sale list of Nurofen Express 400mg Oral Powder.
This consultation seeks your views on the reclassification from pharmacy (P) to general sale list (GSL) of Nurofen Express 400mg Oral Powder.
You are invited to comment on the proposal, a copy of which can be found above. A form for your reply is also attached.
Comments should be sent to Abiodun Aderogba at the MHRA Reclassification Unit.